ArticleCureus2025
Development and Validation of a Machine Learning Model to Predict Postoperative Morbidity and Mortality in Patients With COVID-19 Who Underwent Major Surgery.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Active coronavirus disease (COVID-19) increases the risk of postoperative morbidity and mortality. This study applied machine learning (ML) algorithms to predict postoperative outcomes using preoperative features. Multiple supervised ML models were trained on 153 features from 10,613 patients with COVID-19 who underwent major surgery in 2022 and validated on 5,269 patients from 2021. Among patients with COVID-19, 906 (17.2%) in 2021 and 1,248 (11.8%) in 2022 experienced significantly higher 30-day composite mortality or major morbidity compared with 31,019 (3.2%) of 978,582 patients without COVID-19 in 2021 and 29,874 (3.0%) of 1,001,286 patients without COVID-19 in 2022 (p < 0.001). LightGBM was the best-performing algorithm, achieving an area under the receiver operating characteristic curve (AUC) and F1 score of 0.865 and 0.512 when trained on 2022 data, and 0.898 and 0.617 when validated on 2021 data, respectively. This model accurately identified patients with COVID-19 at increased risk of postoperative morbidity and mortality and may provide a more objective approach to risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.